Medicare Payment Levels For Lab Technologies Criticized At IoM Meeting

The Health Care Financing Administration needs to adopt principled methodologies for "gap-filling" and "cross-walking" in assigning pricing codes to new lab technologies in order to establish appropriate Medicare payment levels for new lab diagnostics, industry groups commented during an Institute of Medicine public meeting Jan. 20 in Washington, D.C.